VIVOBIOT

HealthcareBiotechnology0
Vivo Bio Tech Ltd
₹18.73
Previous trading day close · Data updates nightly
46/100
Below AvgResearch Score
Market Cap
N/A
P/E Ratio
-30.65
Negative earnings
P/B Ratio
0.67
Reasonable
ROE
11.0%
Weak
ROCE
7.2%
Average
Debt / Equity
0.72
Moderate
Div. Yield
N/A
EV/EBITDA
8.02
Attractive
Data as of previous trading day close · Updated nightly
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated nightly
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
39/100
Growth
Revenue, EPS, profit growth
40/100
Valuation
PE, PB, EV/EBITDA vs sector
50/100
Risk
Debt levels, volatility, coverage
59/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
-30.65(Negative earnings)
Forward P/E
N/A
P/B Ratio
0.67(Reasonable)
P/S Ratio
0.97(Good)
EV/EBITDA
8.02(Attractive)
Dividend Yield
N/A
5Y CAGR
-21.3%(Moderate)
Revenue Growth
14.1%(Moderate)
Profitability
ROE
11.0%(Average)
ROCE
7.2%(Average)
ROA
5.2%(Average)
Net Margin
11.1%(Decent)
EBITDA Margin
40.0%
Financial Health
Debt to Equity
0.72(Moderate)
Current Ratio
1.51(Healthy)
Quick Ratio
1.23(Good)
Interest Coverage
1.82x(Low)
Technical Indicators
Based on previous trading day close
Volume
14.2K
Shareholding Pattern
Promoter
35.4%
Low stake
FII
0.0%
DII / MF
0.0%
Share VIVOBIOT
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates nightly after market close. Please consult a SEBI-registered advisor before investing.
VIVOBIOT Share Price - ₹18.73 | Research Score & Analysis | StockSage Pro